261 related articles for article (PubMed ID: 12188883)
1. Selectively replicating adenoviruses for oncolytic therapy.
Yoon TK; Shichinohe T; Laquerre S; Kasahara N
Curr Cancer Drug Targets; 2001 Aug; 1(2):85-107. PubMed ID: 12188883
[TBL] [Abstract][Full Text] [Related]
2. An oncolytic adenovirus selective for retinoblastoma tumor suppressor protein pathway-defective tumors: dependence on E1A, the E2F-1 promoter, and viral replication for selectivity and efficacy.
Jakubczak JL; Ryan P; Gorziglia M; Clarke L; Hawkins LK; Hay C; Huang Y; Kaloss M; Marinov A; Phipps S; Pinkstaff A; Shirley P; Skripchenko Y; Stewart D; Forry-Schaudies S; Hallenbeck PL
Cancer Res; 2003 Apr; 63(7):1490-9. PubMed ID: 12670895
[TBL] [Abstract][Full Text] [Related]
3. Replicative oncolytic adenoviruses in multimodal cancer regimens.
Post DE; Khuri FR; Simons JW; Van Meir EG
Hum Gene Ther; 2003 Jul; 14(10):933-46. PubMed ID: 12869212
[TBL] [Abstract][Full Text] [Related]
4. Replicating adenoviruses in cancer therapy.
Dobbelstein M
Curr Top Microbiol Immunol; 2004; 273():291-334. PubMed ID: 14674605
[TBL] [Abstract][Full Text] [Related]
5. Cancer gene therapy with oncolytic adenoviruses.
Guse K; Hemminki A
J BUON; 2009 Sep; 14 Suppl 1():S7-15. PubMed ID: 19785073
[TBL] [Abstract][Full Text] [Related]
6. Use of replicating oncolytic adenoviruses in combination therapy for cancer.
Chu RL; Post DE; Khuri FR; Van Meir EG
Clin Cancer Res; 2004 Aug; 10(16):5299-312. PubMed ID: 15328165
[TBL] [Abstract][Full Text] [Related]
7. Chapter four--Design of improved oncolytic adenoviruses.
Alemany R
Adv Cancer Res; 2012; 115():93-114. PubMed ID: 23021243
[TBL] [Abstract][Full Text] [Related]
8. Virotherapeutics: conditionally replicative adenoviruses for viral oncolysis.
Nettelbeck DM
Anticancer Drugs; 2003 Sep; 14(8):577-84. PubMed ID: 14501378
[TBL] [Abstract][Full Text] [Related]
9. Combination of oncolytic adenovirus and endostatin inhibits human retinoblastoma in an in vivo mouse model.
Wang H; Wei F; Li H; Ji X; Li S; Chen X
Int J Mol Med; 2013 Feb; 31(2):377-85. PubMed ID: 23229955
[TBL] [Abstract][Full Text] [Related]
10. Beyond oncolytic virotherapy: replication-competent retrovirus vectors for selective and stable transduction of tumors.
Dalba C; Klatzmann D; Logg CR; Kasahara N
Curr Gene Ther; 2005 Dec; 5(6):655-67. PubMed ID: 16457654
[TBL] [Abstract][Full Text] [Related]
11. [Advances in research on oncolytic adenoviruses in tumor therapy].
Zhou XL; Tang WR
Bing Du Xue Bao; 2014 May; 30(3):318-24. PubMed ID: 25118389
[TBL] [Abstract][Full Text] [Related]
12. Selectively replicating oncolytic adenoviruses as cancer therapeutics.
Yu DC; Working P; Ando D
Curr Opin Mol Ther; 2002 Oct; 4(5):435-43. PubMed ID: 12435044
[TBL] [Abstract][Full Text] [Related]
13. [Oncolytic adenoviruses in anti-cancer therapy: current status and perspectives].
Sviatchenko VA; Tarasova MV; Netesov SV; Chumakov PM
Mol Biol (Mosk); 2012; 46(4):556-69. PubMed ID: 23113343
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of E1B gene-attenuated replicating adenoviruses for cancer gene therapy.
Kim J; Cho JY; Kim JH; Jung KC; Yun CO
Cancer Gene Ther; 2002 Sep; 9(9):725-36. PubMed ID: 12189522
[TBL] [Abstract][Full Text] [Related]
15. Insulated hsp70B' promoter: stringent heat-inducible activity in replication-deficient, but not replication-competent adenoviruses.
Rohmer S; Mainka A; Knippertz I; Hesse A; Nettelbeck DM
J Gene Med; 2008 Apr; 10(4):340-54. PubMed ID: 18265421
[TBL] [Abstract][Full Text] [Related]
16. Functional interactions of antiapoptotic proteins and tumor necrosis factor in the context of a replication-competent adenovirus.
Liu TC; Wang Y; Hallden G; Brooks G; Francis J; Lemoine NR; Kirn D
Gene Ther; 2005 Sep; 12(17):1333-46. PubMed ID: 15920462
[TBL] [Abstract][Full Text] [Related]
17. Development of transcriptionally regulated oncolytic adenoviruses.
Ko D; Hawkins L; Yu DC
Oncogene; 2005 Nov; 24(52):7763-74. PubMed ID: 16299536
[TBL] [Abstract][Full Text] [Related]
18. Tissue-specific promoters for cancer gene therapy.
Saukkonen K; Hemminki A
Expert Opin Biol Ther; 2004 May; 4(5):683-96. PubMed ID: 15155160
[TBL] [Abstract][Full Text] [Related]
19. Adenovirus vectors for gene therapy, vaccination and cancer gene therapy.
Wold WS; Toth K
Curr Gene Ther; 2013 Dec; 13(6):421-33. PubMed ID: 24279313
[TBL] [Abstract][Full Text] [Related]
20. Replication-selective oncolytic viruses in the treatment of cancer.
Everts B; van der Poel HG
Cancer Gene Ther; 2005 Feb; 12(2):141-61. PubMed ID: 15472714
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
